EUVIMEDEUVIMED entdecken
Crossref

K33 only mutant ubiquitin augments bone marrow‐derived dendritic cell‐mediated CTL priming via PI3K‐Akt pathway

Yi Yun Liang, Xiao Yan Liao, Jun Jun Jia, Yi Zhen Yin, Yue Hua Zhang, Feng Guang Gao iD

Immunology · 2024

DOI: 10.1111/imm.13787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2024. Verfasst von Yi Yun Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine Science, School of Medicine, Xiamen University, Xiamen, Fujian, People's Republic of China. Hauptthemen laut MEDLINE: Dendritic Cells, Proto-Oncogene Proteins c-akt, Ubiquitin, Signal Transduction. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To explore the effect of K33 only mutant ubiquitin (K33O) on bone marrow‐derived dendritic cells' (BMDCs') maturity, antigen uptake capability, surface molecule expressions and BMDC‐mediated CTL priming, and further investigate the role of PI3K‐Akt engaged in K33O‐increased BMDC maturation, antigen uptake and presentation, surface molecule expressions and BMDC‐based CTL priming. BMDCs were conferred K33O and other ubiquitin mutants (K33R, K48R, K63R‐mutant ubiquitin) incubation or LY294002 and wortmannin pretreatment. PI3K‐Akt phosphorylation, antigen uptake, antigenic presentation and CD86/MHC class I expression in BMDC were determined by western blot or flow cytometry. BMDC‐based CTL proliferation and priming were determined by in vitro mixed lymphocyte reaction (MLR), ex vivo enzyme‐linked immunospot assay (Elispot) and flow cytometry with intracellular staining, respectively. The treatment with K33O effectively augmented PI3K‐Akt phosphorylation, BMDCs' antigen uptake, antigenic presentation, CD86/MHC class I and CD11c expressions. MLR, Elispot and flow cytometry revealed that K33O treatment obviously enhanced CTL proliferation, CTL priming and perforin/granzyme B expression. The pretreatment with PI3K‐Akt inhibitors efficiently abrogated K33O's effects on BMDC. The replenishment of K33 only mutant ubiquitin augments BMDC‐mediated CTL priming in bone marrow‐derived dendritic cells via PI3K‐Akt signalling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsProto-Oncogene Proteins c-aktUbiquitinSignal TransductionT-Lymphocytes, CytotoxicBone Marrow CellsPhosphatidylinositol 3-KinasesAntigen PresentationAnimalsMiceMice, Inbred C57BLPhosphorylationLymphocyte ActivationCell DifferentiationMutationMorpholinesLymphocyte Culture Test, MixedCell ProliferationB7-2 AntigenCells, CulturedChromonesWortmanninAndrostadienes

Stichwörter der Autor:innen

AktCTLK33 only mutant ubiquitinPI3Kbone marrow‐derived dendritic cells

Substanzen

Proto-Oncogene Proteins c-aktUbiquitinPhosphatidylinositol 3-KinasesMorpholinesB7-2 Antigen2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneChromonesWortmanninAndrostadienes

Autor:innen und Institutionen

  • Department of Basic Medicine Science, School of Medicine, Xiamen University, Xiamen, Fujian, People's Republic of China.
  • Laboratory Animal Center, Xiamen University, Xiamen, Fujian, People's Republic of China.

ORCID-Profile: Feng Guang Gao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liang, Y. Y., Liao, X. Y., Jia, J. J., Yin, Y. Z., Zhang, Y. H., & Gao, F. G. (2024). K33 only mutant ubiquitin augments bone marrow‐derived dendritic cell‐mediated CTL priming via PI3K‐Akt pathway. Immunology. https://doi.org/10.1111/imm.13787

Vancouver

Liang YY, Liao XY, Jia JJ, Yin YZ, Zhang YH, Gao FG. K33 only mutant ubiquitin augments bone marrow‐derived dendritic cell‐mediated CTL priming via PI3K‐Akt pathway. Immunology. 2024. doi:10.1111/imm.13787

BibTeX
@article{Liang2024,
  author = {Liang, Yi Yun and Liao, Xiao Yan and Jia, Jun Jun and Yin, Yi Zhen and Zhang, Yue Hua and Gao, Feng Guang},
  title = {K33 only mutant ubiquitin augments bone marrow‐derived dendritic cell‐mediated CTL priming via PI3K‐Akt pathway},
  journal = {Immunology},
  year = {2024},
  doi = {10.1111/imm.13787}
}
Kostenlos starten →